Renowned investment firm Renaissance Technologies, led by Jim Simons (Trades, Portfolio), has recently increased its stake in Corcept Therapeutics Inc (NASDAQ:CORT), a pharmaceutical company specializing in the treatment of severe metabolic, oncologic, and neuropsychiatric disorders. This transaction underscores the firm's confidence in Corcept Therapeutics, even as it navigates the volatile biotechnology sector.
On December 29, 2023, Renaissance Technologies, led by Jim Simons (Trades, Portfolio), made a notable addition to its investment portfolio by acquiring 2,669,209 shares of Smith & Wesson Brands Inc (NASDAQ:SWBI), a leading firearm manufacturer. Jim Simons (Trades, Portfolio), the founder of Renaissance Technologies Corporation, has been a prominent figure in the investment world since 1982.
On December 29, 2023, Renaissance Technologies, led by Jim Simons (Trades, Portfolio), made a notable addition to its investment portfolio by acquiring 11,188 shares of Data I/O Corp (NASDAQ:DAIO). Despite the trade having a seemingly negligible impact on the overall portfolio, the move is significant given Simons's reputation for data-driven investment decisions.
Overview of Jim Simons (Trades, Portfolio)'s Recent Trade Renaissance Technologies, led by Jim Simons (Trades, Portfolio), has recently adjusted its holdings in Friedman Industries Inc (FRD), a company engaged in steel processing. The transaction was executed at a price of $15.46 per share, leaving the firm with a total of 374,782 shares in Friedman Industries, which now represents 0.01% of the portfolio and 5.38% of the company's outstanding shares.
On December 29, 2023, Renaissance Technologies, led by Jim Simons (Trades, Portfolio), made a notable addition to its investment portfolio by acquiring 699,115 shares of BankFinancial Corp (NASDAQ:BFIN). Despite the modest size of the trade, with a 0.01% portfolio impact, this move by the prominent investment firm has garnered attention in the financial community.